Business ❯ Pharmaceutical Industry

Clinical Trials

Drug Development Regulatory Affairs Drug Approval Process Regulatory Approval Weight Loss Drugs Investment FDA Approvals Drug Safety Regulatory Submissions FDA Approval Process

FDA Clears Once-Weekly Saphnelo Pen for Self-Injection in Lupus

Phase 3 data showed lower disease activity with safety matching the IV form.

Insmed Halts Brensocatib in Hidradenitis Suppurativa After Phase 2b Trial Fails

Eupraxia Reports Early EoE Trial Data With Near‑Normal Tissue at Top Dose

FDA Clears Arrowhead’s Redemplo for FCS, Marking the Biotech’s First Approval

Pluvicto Added to Standard Care Extends rPFS in PSMA-Positive Metastatic Hormone-Sensitive Prostate Cancer

Phase 3 Trial Finds Tukysa Improves PFS in First-Line Maintenance for HER2-Positive Metastatic Breast Cancer

Eli Lilly Halts Diabetes Arm of Bimagrumab Obesity Trial Weeks After Launch

UK Grants Pharmacies Power to Prescribe NHS Weight-Loss Jabs in 10-Year Health Plan

FDA Halts Rocket’s RP-A501 Gene Therapy for Danon Disease After Patient’s Death

German Court Approves Pharmacist's Production of Unapproved Cancer Drug

Sanofi and J&J Halt E. coli Vaccine Trial After Insufficient Efficacy

Viking Therapeutics' Weight Loss Drug Shows Promise in Early Trial